EUVIMEDEUVIMED entdecken
Open Access

Trends in Human Papillomavirus Testing Among Patients With Oropharyngeal Cancer

Katie M Carlson, Nana-Hawwa Abdul-Rahman, Rebecca A Deek, Alexis Cenname, Wesley Cai, Kathryn Demanelis, Dan P Zandberg, Kevin J Contrera, Jose P Zevallos, Jeremy Martinson, Angela L Mazul

JAMA Network Open · 29.07.2025 · 8 (7) · e2523917

DOI: 10.1001/jamanetworkopen.2025.23917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 29.07.2025. Verfasst von Katie M Carlson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Due to the prognostic value of human papillomavirus (HPV) status, HPV testing for oropharyngeal squamous cell carcinoma (OPSCC) has been recommended since 2012. However, recent HPV testing rates and associated sociodemographic and clinical factors are unknown.

Objective

To examine HPV testing rates stratified by sociodemographic and clinical factors and factors associated with increased likelihood of not receiving HPV testing from 2013 to 2021. Design, Setting, and Participants In this hospital-based cross-sectional study, the National Cancer Database (NCDB) was queried in 2024 for any patient diagnosed with OPSCC from 2013 to 2021, creating a retrospective cohort of 135 756 individuals. Two subsets were formed based on year of diagnosis: 2013-2017 and 2018-2021. Exposures Sociodemographic characteristics (ie, age, race and ethnicity, sex, insurance status, zip code median income, and zip code educational attainment) and clinical factors (ie, year of diagnosis, subsite, overall stage, and facility type). Main Outcomes and Measures The outcome variable was HPV testing status (tested vs not tested). Differences in HPV testing were assessed using χ 2 and Mann-Whitney U testing. Trends in HPV testing were examined with annual percentage change longitudinally from 2013 to 2021. Factors associated with the increased probability of not receiving HPV testing were identified using Poisson regression.

Results

The total population was 135 756 patients with OPSCC (7.3% Black, 3.9% Hispanic, 86.2% White, 2.6% other; 83.4% male). From 2013 to 2017, a total of 70 911 patients were diagnosed with OPSCC (82.9% male and 17.1% female). Of these, 50 494 (71.2%) were tested for HPV (median [IQR] age, 60 [47-73] years), whereas 20 417 (28.8%) were not tested for HPV or had unknown testing status (median [IQR], 62 [48-76] years). From 2018 to 2021, a total of 64 845 patients were diagnosed with OPSCC (83.9% male and 16.1% female). Of these, 60 184 (92.8%) were tested for HPV (median [IQR] age, 63 [50-76] years), whereas 4661 (7.2%) were not tested for HPV or had unknown testing status (median [IQR], 64 [49-79] years). In a multivariable analysis, patients with OPSCC who were diagnosed from 2018 to 2021 at community (prevalence ratio [PR], 1.36; 95% CI, 1.20-1.54), comprehensive community (PR, 1.20; 95% CI, 1.11-1.29), or integrated network (PR, 1.17; 95% CI, 1.06-1.28) cancer programs were more likely not to be tested for HPV compared with academic or research programs. Patients with OPSCC diagnosed from 2018 to 2021 of Black (PR, 1.18; 95% CI, 1.05-1.33) or other race (PR, 1.39; 95% CI, 1.17-1.66) were more likely not to be tested compared with White patients. Conclusions and Relevance This cross-sectional study found substandard HPV testing rates and HPV testing disparities for patients with OPSCC in the NCDB from 2013 to 2021. These findings underscore the need for increased scrutiny of HPV testing practices, particularly at community cancer programs and among patients of races other than White, to ensure that OPSCC guidelines are met.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsPapillomavirus InfectionsHumansMaleFemaleMiddle AgedCross-Sectional StudiesRetrospective StudiesAgedUnited StatesAdultHuman Papillomavirus Viruses

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Cancer Epidemiology and Prevention Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Department of Biostatistics and Health Data Science, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
  • University of Pittsburgh Health Sciences Library System, Pittsburgh, Pennsylvania.
  • Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Zitieren

APA

Carlson, K. M., Abdul-Rahman, N. H., Deek, R. A., Cenname, A., Cai, W., Demanelis, K., Zandberg, D. P., Contrera, K. J., Zevallos, J. P., Martinson, J., & Mazul, A. L. (2025). Trends in Human Papillomavirus Testing Among Patients With Oropharyngeal Cancer. JAMA Network Open, 8(7), e2523917. https://doi.org/10.1001/jamanetworkopen.2025.23917

Vancouver

Carlson KM, Abdul-Rahman NH, Deek RA, Cenname A, Cai W, Demanelis K, et al. Trends in Human Papillomavirus Testing Among Patients With Oropharyngeal Cancer. JAMA Network Open. 2025;8(7):e2523917. doi:10.1001/jamanetworkopen.2025.23917

BibTeX
@article{Carlson2025,
  author = {Carlson, Katie M and Abdul-Rahman, Nana-Hawwa and Deek, Rebecca A and Cenname, Alexis and Cai, Wesley and Demanelis, Kathryn and Zandberg, Dan P and Contrera, Kevin J and Zevallos, Jose P and Martinson, Jeremy and Mazul, Angela L},
  title = {Trends in Human Papillomavirus Testing Among Patients With Oropharyngeal Cancer},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {7},
  pages = {e2523917},
  doi = {10.1001/jamanetworkopen.2025.23917}
}
Kostenlos starten →